Apyx Medical Corporation APYX
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 22.08% | 32.45% | 34.75% | 12.10% | -6.39% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 22.08% | 32.45% | 34.75% | 12.10% | -6.39% |
| Cost of Revenue | 16.88% | 21.25% | 36.27% | 1.04% | -7.86% |
| Gross Profit | 25.23% | 39.89% | 33.86% | 19.31% | -5.47% |
| SG&A Expenses | 11.89% | 2.01% | 1.37% | -11.85% | -23.96% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 12.50% | 7.37% | 10.90% | -9.34% | -21.19% |
| Operating Income | 29.84% | 70.14% | 100.36% | 77.11% | 53.60% |
| Income Before Tax | 20.09% | 51.49% | 74.92% | 59.76% | 43.56% |
| Income Tax Expenses | 153.06% | 191.84% | 5.62% | 30.00% | -2.00% |
| Earnings from Continuing Operations | 17.82% | 48.63% | 73.38% | 58.62% | 43.24% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -327.50% | 59.09% | -290.32% | -238.10% | -233.33% |
| Net Income | 14.16% | 49.20% | 71.93% | 57.81% | 42.37% |
| EBIT | 29.84% | 70.14% | 100.36% | 77.11% | 53.60% |
| EBITDA | 34.07% | 75.66% | 107.98% | 80.87% | 54.70% |
| EPS Basic | 20.26% | 52.70% | 74.57% | 64.14% | 50.95% |
| Normalized Basic EPS | 20.31% | 55.66% | 75.10% | 64.67% | 50.77% |
| EPS Diluted | 20.26% | 52.70% | 74.57% | 64.14% | 50.95% |
| Normalized Diluted EPS | 20.31% | 55.66% | 75.10% | 64.67% | 50.77% |
| Average Basic Shares Outstanding | 7.66% | 7.40% | 10.33% | 17.62% | 17.56% |
| Average Diluted Shares Outstanding | 7.66% | 7.40% | 10.33% | 17.62% | 17.56% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |